-
Product Insights
NewNet Present Value Model: Horizon Therapeutics Plc’s Fipaxalparant
OverviewDetermining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
FPL Horizon Solar PV Park
FPL Horizon Solar PV Park is a solar PV project located in Florida, United States. The project is owned and developed by Florida Power & Light Co. The project came online in 2018. Empower your strategies with our FPL Horizon Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Celtic Horizon Offshore Wind Project
Celtic Horizon Offshore Wind Project is an offshore wind project located in Irish Sea, Ireland. The project is owned by Bord na Mona Plc; EDP Renovaveis SA; Engie SA and is developed by Bord na Mona Plc; Ocean Winds SL. The project is expected to come online in 2030. Empower your strategies with our Celtic Horizon Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report...
-
Product Insights
High Horizons Solar PV Park
High Horizons Solar PV Park is a solar PV project located in Wyoming, United States. The project is owned and being developed by OPDE Holding SA. The project is at the permitting stage. Empower your strategies with our High Horizons Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewNet Present Value Model: Horizon Therapeutics Plc’s HZN-825
Empower your strategies with our Net Present Value Model: Horizon Therapeutics Plc's HZN-825 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Thematic Analysis
NewSemiconductors Sector Scorecard, Q1 2024 Update – Thematic Intelligence
Companies scoring strongly in artificial intelligence (AI) and geopolitics-related themes lead the thematic screen of GlobalData’s semiconductors sector scorecard. Indeed, the AI, AI chips, geopolitics, and China impact themes jointly account for 50% of the weighting of the thematic screen, reflecting both the growing importance of AI, particularly generative AI, in the industry and the impact of the ongoing US-China trade dispute. Among the thematic leaders are companies with either advanced AI products, such as Nvidia, Amazon, Tesla, and Alibaba,...
-
Company Insights
Innovation and Patenting activity of Aker Horizons AS Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Aker Horizons AS Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of First Horizon Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of First Horizon Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Company Insights
Innovation and Patenting activity of Horizon Therapeutics Plc Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Horizon Therapeutics Plc Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Thematic Analysis
NewCybersecurity – Thematic Intelligence
Cybersecurity Thematic Intelligence Report Overview The prospect of offensive attacks using artificial intelligence (AI) is prompting an increase in cybersecurity budgets as organizations try to understand the impact of generative AI on their security. Both start-ups and maturing cyber companies will be on the radar of larger cybersecurity companies looking for products and talent. Moreover, cybersecurity M&A will be a strong focus during 2024 as a small group of private equity players are buying up numerous cybersecurity companies. Buy the...